Bordetella Pertussis Colonisation Challenge Study
NCT03751514
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Whooping Cough
Interventions
BIOLOGICAL:
Bordetella Pertussis B1917
DRUG:
Azithromycin 500 mg
OTHER:
Sterile Saline
Sponsor
University of Southampton
Collaborators
[object Object]
[object Object]